AI assistant
Sending…
Jasper Therapeutics, Inc. — Director's Dealing 2019
Nov 20, 2019
34406_dirs_2019-11-19_d0c1e872-960b-4611-ab47-87a78e6368b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Amplitude Healthcare Acquisition Corp (AMHCU)
CIK: 0001788028
Period of Report: 2019-11-19
Reporting Person: Reicin Glenn (Director)
More from Jasper Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 21
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Feb 10
Major Shareholding Notification
2026
Jan 26
Regulatory Filings
2026
Jan 8
Board/Management Information
2026
Jan 7
Director's Dealing
2026
Jan 6